Form 4: LifeStance Health Group Director Kenneth Burdick Reports Stock Transactions

Director Kenneth Burdick reports acquisition and disposal of LifeStance Health Group stock related to RSU and PSU vesting and tax withholding.

Summary

• Kenneth Burdick, a director of LifeStance Health Group, reported several transactions involving the company's common stock.
• On March 6, 2025, he acquired 95,178 shares of common stock through restricted stock units (RSUs) and the company withheld 53,602 shares for tax obligations at a price of $7.88.
• On March 7, 2025, he acquired 283,172, 423,790 shares of common stock through performance-based restricted stock units (PSUs) and the company withheld 111,430 and 166,762 shares for tax obligations at a price of $7.59.
• Following these transactions, Burdick directly owns 3,404,718 shares of LifeStance Health Group common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions related to vesting and tax obligations, which are routine.

Positives

• The vesting of RSUs and PSUs indicates that performance metrics or time-based conditions have been met, which could be viewed positively.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• Shareholders may be interested in the transactions of company insiders as an indicator of management's confidence in the company.

Key Dates